| Bioactivity | AN15368 is an orally active small-molecule prodrug that can be activated by parasite carboxypeptidase to produce a compound that targets the messenger RNA processing pathway in T. cruzi. cruzi. AN15368 has the potential to prevent and treat Chagas disease potential[1]. |
| Name | AN15368 |
| CAS | 2152662-92-3 |
| Formula | C20H28BNO6 |
| Molar Mass | 389.25 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Angel M Padilla, et al. Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primates. Nat Microbiol. 2022 Oct;7(10):1536-1546 |
AN15368
CAS: 2152662-92-3 F: C20H28BNO6 W: 389.25
AN15368 is an orally active small-molecule prodrug that can be activated by parasite carboxypeptidase to produce a compo
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.